Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Meningeal Neoplasms × eribulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 4 Sarcoma 2 Urinary Bladder Neoplasms 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 HR+HER2- Breast Cancer 1 HER2-low Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Brain Neoplasms 1

Interventions

paclitaxel-Angiopep-2 conjugate 1 eribulin 1 Methotrexate 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡